Reinhart Partners LLC. Trims Holdings in Encompass Health Co. (NYSE:EHC)

Reinhart Partners LLC. cut its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 14.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 562,968 shares of the company's stock after selling 93,352 shares during the quarter. Encompass Health accounts for approximately 2.1% of Reinhart Partners LLC.'s holdings, making the stock its 22nd biggest position. Reinhart Partners LLC. owned approximately 0.56% of Encompass Health worth $57,017,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Encompass Health by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company's stock worth $960,817,000 after purchasing an additional 138,196 shares in the last quarter. Invesco Ltd. raised its stake in Encompass Health by 3.3% in the 4th quarter. Invesco Ltd. now owns 5,536,251 shares of the company's stock valued at $511,273,000 after purchasing an additional 176,135 shares during the last quarter. Alliancebernstein L.P. raised its stake in Encompass Health by 6.0% in the 4th quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company's stock valued at $191,799,000 after purchasing an additional 117,617 shares during the last quarter. FMR LLC raised its stake in Encompass Health by 0.8% in the 4th quarter. FMR LLC now owns 1,973,846 shares of the company's stock valued at $182,285,000 after purchasing an additional 15,831 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in Encompass Health by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company's stock valued at $155,176,000 after purchasing an additional 6,164 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on EHC shares. Royal Bank of Canada boosted their target price on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Wall Street Zen downgraded shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday. UBS Group lifted their price target on Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a report on Monday, April 28th. Truist Financial restated a "buy" rating and issued a $135.00 price target (up previously from $116.00) on shares of Encompass Health in a report on Monday, April 28th. Finally, KeyCorp lifted their price target on Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a report on Tuesday, May 27th. Eight equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $127.00.

Encompass Health Trading Down 0.9%

Shares of NYSE:EHC traded down $1.11 during trading on Tuesday, reaching $119.19. 604,957 shares of the stock were exchanged, compared to its average volume of 701,336. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. Encompass Health Co. has a 12-month low of $82.74 and a 12-month high of $123.13. The firm has a market cap of $12.01 billion, a price-to-earnings ratio of 26.72, a price-to-earnings-growth ratio of 2.31 and a beta of 0.89. The firm's 50-day moving average price is $112.67 and its 200 day moving average price is $103.04.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The business had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. During the same quarter in the previous year, the business earned $1.12 EPS. The company's revenue for the quarter was up 10.6% on a year-over-year basis. On average, sell-side analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.57%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health's dividend payout ratio is presently 14.05%.

Insiders Place Their Bets

In other Encompass Health news, CEO Mark J. Tarr sold 118,384 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the transaction, the chief executive officer now owns 527,070 shares in the company, valued at $64,054,817.10. This represents a 18.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the company's stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the completion of the transaction, the insider now owns 11,958 shares of the company's stock, valued at approximately $1,394,422.38. This represents a 26.35% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 132,663 shares of company stock worth $16,034,082 in the last 90 days. 2.00% of the stock is owned by company insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.